209 related articles for article (PubMed ID: 37801459)
21. Probiotics for the Prevention of Pediatric Antibiotic-Associated Diarrhea.
Hayes SR; Vargas AJ
Explore (NY); 2016; 12(6):463-466. PubMed ID: 27688016
[TBL] [Abstract][Full Text] [Related]
22. Clinical study on sequential treatment of severe diarrhea irritable bowel syndrome with precision probiotic strains transplantation capsules, fecal microbiota transplantation capsules and live combined bacillus subtilis and enterococcus faecium capsules.
Lv L; Ruan G; Ping Y; Cheng Y; Tian Y; Xiao Z; Zhao X; Chen D; Wei Y
Front Cell Infect Microbiol; 2022; 12():1025889. PubMed ID: 36250045
[TBL] [Abstract][Full Text] [Related]
23. Compositional Changes in the Gut Microbiota of Responders and Non-responders to Probiotic Treatment Among Patients With Diarrhea-predominant Irritable Bowel Syndrome: A Post Hoc Analysis of a Randomized Clinical Trial.
Shin SY; Park S; Moon JM; Kim K; Kim JW; Chun J; Lee TH; Choi CH;
J Neurogastroenterol Motil; 2022 Oct; 28(4):642-654. PubMed ID: 36250371
[TBL] [Abstract][Full Text] [Related]
24. Effect of a Preparation of Four Probiotics on Symptoms of Patients with Irritable Bowel Syndrome: Association with Intestinal Bacterial Overgrowth.
Leventogiannis K; Gkolfakis P; Spithakis G; Tsatali A; Pistiki A; Sioulas A; Giamarellos-Bourboulis EJ; Triantafyllou K
Probiotics Antimicrob Proteins; 2019 Jun; 11(2):627-634. PubMed ID: 29508268
[TBL] [Abstract][Full Text] [Related]
25. Effects of probiotic fermented milk on symptoms and intestinal flora in patients with irritable bowel syndrome: a randomized, placebo-controlled trial.
Søndergaard B; Olsson J; Ohlson K; Svensson U; Bytzer P; Ekesbo R
Scand J Gastroenterol; 2011 Jun; 46(6):663-72. PubMed ID: 21443416
[TBL] [Abstract][Full Text] [Related]
26. A Mixture of 3 Bifidobacteria Decreases Abdominal Pain and Improves the Quality of Life in Children With Irritable Bowel Syndrome: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Crossover Trial.
Giannetti E; Maglione M; Alessandrella A; Strisciuglio C; De Giovanni D; Campanozzi A; Miele E; Staiano A
J Clin Gastroenterol; 2017 Jan; 51(1):e5-e10. PubMed ID: 27306945
[TBL] [Abstract][Full Text] [Related]
27. Clinical and Microbiological Effect of a Multispecies Probiotic Supplementation in Celiac Patients With Persistent IBS-type Symptoms: A Randomized, Double-Blind, Placebo-controlled, Multicenter Trial.
Francavilla R; Piccolo M; Francavilla A; Polimeno L; Semeraro F; Cristofori F; Castellaneta S; Barone M; Indrio F; Gobbetti M; De Angelis M
J Clin Gastroenterol; 2019 Mar; 53(3):e117-e125. PubMed ID: 29688915
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of double-coated probiotics for irritable bowel syndrome: a randomized double-blind controlled trial.
Han K; Wang J; Seo JG; Kim H
J Gastroenterol; 2017 Apr; 52(4):432-443. PubMed ID: 27178566
[TBL] [Abstract][Full Text] [Related]
29. Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome.
Zeng J; Li YQ; Zuo XL; Zhen YB; Yang J; Liu CH
Aliment Pharmacol Ther; 2008 Oct; 28(8):994-1002. PubMed ID: 18671775
[TBL] [Abstract][Full Text] [Related]
30. Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study.
Guglielmetti S; Mora D; Gschwender M; Popp K
Aliment Pharmacol Ther; 2011 May; 33(10):1123-32. PubMed ID: 21418261
[TBL] [Abstract][Full Text] [Related]
31. Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders: a double-blind study.
Ringel-Kulka T; Palsson OS; Maier D; Carroll I; Galanko JA; Leyer G; Ringel Y
J Clin Gastroenterol; 2011 Jul; 45(6):518-25. PubMed ID: 21436726
[TBL] [Abstract][Full Text] [Related]
32. Safety and efficacy of purified clinoptilolite-tuff treatment in patients with irritable bowel syndrome with diarrhea: Randomized controlled trial.
Anderle K; Wolzt M; Moser G; Keip B; Peter J; Meisslitzer C; Gouya G; Freissmuth M; Tschegg C
World J Gastroenterol; 2022 Dec; 28(46):6573-6588. PubMed ID: 36569277
[TBL] [Abstract][Full Text] [Related]
33. Effect of probiotic species on irritable bowel syndrome symptoms: A bring up to date meta-analysis.
Ortiz-Lucas M; Tobías A; Saz P; Sebastián JJ
Rev Esp Enferm Dig; 2013 Jan; 105(1):19-36. PubMed ID: 23548007
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the kinetics of intestinal colonization by associating 5 probiotic bacteria assumed either in a microencapsulated or in a traditional, uncoated form.
Piano MD; Carmagnola S; Ballarè M; Balzarini M; Montino F; Pagliarulo M; Anderloni A; Orsello M; Tari R; Sforza F; Mogna L; Mogna G
J Clin Gastroenterol; 2012 Oct; 46 Suppl():S85-92. PubMed ID: 22955366
[TBL] [Abstract][Full Text] [Related]
35. Two Lactobacilli strains as adjuvant therapy in the management of irritable bowel syndrome: a randomized control trial.
Shanshal SA; Alsaaty MH; Al-Qazaz H; Al-Zidan RN
Ceska Slov Farm; 2024; 72(5):233-241. PubMed ID: 38195431
[TBL] [Abstract][Full Text] [Related]
36. Two Lactobacilli strains as adjuvant therapy in the management of irritable bowel syndrome: a randomized control trial.
Shanshal SA; Alsaaty MH; Al-Qazaz H; Al-Zidan RN
Ceska Slov Farm; 2024; 73(1):233-241. PubMed ID: 38185646
[TBL] [Abstract][Full Text] [Related]
37. Correlation between Intestinal Microflora in Irritable Bowel Syndrome and Severity.
Ji M; Huang H; Lan X
Dis Markers; 2022; 2022():1031844. PubMed ID: 35634439
[TBL] [Abstract][Full Text] [Related]
38. Altered gastrointestinal microbiota in irritable bowel syndrome and its modification by diet: probiotics, prebiotics and the low FODMAP diet.
Staudacher HM; Whelan K
Proc Nutr Soc; 2016 Aug; 75(3):306-18. PubMed ID: 26908093
[TBL] [Abstract][Full Text] [Related]
39. Heat-inactivated Bifidobacterium bifidum MIMBb75 (SYN-HI-001) in the treatment of irritable bowel syndrome: a multicentre, randomised, double-blind, placebo-controlled clinical trial.
Andresen V; Gschossmann J; Layer P
Lancet Gastroenterol Hepatol; 2020 Jul; 5(7):658-666. PubMed ID: 32277872
[TBL] [Abstract][Full Text] [Related]
40. Bifidobacterium-Rich Fecal Donor May Be a Positive Predictor for Successful Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome.
Mizuno S; Masaoka T; Naganuma M; Kishimoto T; Kitazawa M; Kurokawa S; Nakashima M; Takeshita K; Suda W; Mimura M; Hattori M; Kanai T
Digestion; 2017; 96(1):29-38. PubMed ID: 28628918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
